INNOVATE (VATE) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for June 12, 2025, with virtual participation available to shareholders.
Shareholders are encouraged to review proxy materials and vote by June 11, 2025.
Voting matters and shareholder proposals
Election of four directors: Avram A. Glazer, Warren H. Gfeller, Brian S. Goldstein, and Amy M. Wilkinson.
Advisory vote on executive compensation (Say on Pay Vote).
Advisory vote on the frequency of Say on Pay Votes (every one, two, or three years).
Ratification of BDO USA, P.C. as independent auditor for fiscal year ending December 31, 2025.
Provision to address any other business that may arise at the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and proposals.
Partial view of Summaries dataset, powered by Quartr API
Latest events from INNOVATE
- Q4 2025 revenue up 61.7% to $382.7M, with strong Infrastructure growth and narrowing net loss.VATE
Q4 202526 Mar 2026 - Q2 net income rose to $14.4M as margins improved and Life Sciences posted record sales.VATE
Q2 20242 Feb 2026 - Q3 revenue dropped 35.5% to $242.2M; growth in Life Sciences and Spectrum, but going concern risk remains.VATE
Q3 202416 Jan 2026 - Revenue declined, but Life Sciences and Spectrum grew; debt reduced and backlog remains strong.VATE
Q4 202425 Dec 2025 - Annual meeting to vote on directors, executive pay, auditor, and governance after major 2024 changes.VATE
Proxy Filing2 Dec 2025 - Annual meeting adjourned for technical reasons; voting postponed to June 18, 2024.VATE
Proxy Filing2 Dec 2025 - Revenue fell 22.7% to $242M, net loss $22M, Life Sciences grew, major debt refinancing completed.VATE
Q2 202523 Nov 2025 - Revenue dropped 13% to $274.2M; backlog and regulatory wins offset high debt risk.VATE
Q1 202515 Nov 2025 - Q3 revenue up 43% to $347.1M, net loss narrowed, and refinancing triggered asset sales.VATE
Q3 202513 Nov 2025